Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Sanofi (OtherSNYNF)

Tipranks - Tipranks - Wed Dec 24, 2025

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Viridian Therapeutics (VRDN – Research Report) and Sanofi (SNYNF – Research Report).

Claim 70% Off TipRanks This Holiday Season

Sanofi (SNYNF)

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi today. The company’s shares closed last Monday at $97.30.

According to TipRanks.com, Vosser is a 3-star analyst with an average return of 1.9% and a 49.4% success rate. Vosser covers the Healthcare sector, focusing on stocks such as Molecular Partners AG, Roche Holding AG, and Novo Nordisk. ;'>

Currently, the analyst consensus on Sanofi is a Strong Buy with an average price target of $121.71, which is a 28.6% upside from current levels. In a report issued on December 15, Goldman Sachs also maintained a Hold rating on the stock with a EUR95.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).